Data Loading...
Global myasthenia gravis treatment market is projected to grow at a considerable CAGR of around 7 Flipbook PDF
Global myasthenia gravis treatment market is projected to grow at a considerable CAGR of around 7
126 Views
61 Downloads
FLIP PDF 346.25KB
Orion Market Research
Global Myasthenia Gravis Treatment Market Size, Competitive Analysis, Share, Forecast- 2020-2026 Request a Free Sample @ https://www.omrglobal.com/request-sample/myasthenia-gravistreatment-market
Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: [email protected] Contact no: +91 780-304-0404
Global myasthenia gravis treatment market is projected to grow at a considerable CAGR of around 7% during the forecast period (2020-2026). Increasing awareness related to the rare diseases, approval of promising drugs, the emergence of biologics along with the high adoption of immunotherapies is the key factor contributing towards the growth of the myasthenia gravis (MG) treatment market across the globe. Myasthenia gravis is a chronic autoimmune, neuromuscular disorder that leads to weakness in the skeletal muscles. Eyes, face, and swallowing are the most affected muscles. Get Free Sample Copy @ https://www.omrglobal.com/request-sample/myasthenia-gravistreatment-market In May 2019, the American Academy of Neurology had approved Eculizumab (Soliris), a particularly high-cost biologic that treats rare and ultra-rare diseases to make treatment of myasthenia gravis patients. Therefore, the emergence of new biologics is expected to drive the growth of the global myasthenia market. Ongoing R&D by government or non-government institutions to find new ways to treat autoimmune disorders is anticipated to offer considerable opportunities to the growth of the global market. However, the high cost of treatment is anticipated to hinder the growth of the myasthenia gravis treatment market across the globe. Browse
for
Full
Report
Description@
https://www.omrglobal.com/industry-
reports/myasthenia-gravis-treatment-market Market Segmentation Global Myasthenia Gravis Treatment Market by Treatment Medication
Cholinesterase Inhibitors
Corticosteroids
Immunosuppressants
Surgery
Others
Global Myasthenia Gravis Treatment Market by End-User
Hospitals
Clinics
Other
Regional Analysis North America
US
Canada
Europe
UK
Germany
Italy
Spain
France
Rest of Europe
Asia-Pacific
China
India
Japan
Rest of Asia-Pacific
Rest of the World Company Profiles
AbbVie, Inc.
Alexion Pharmaceutical, Inc.
Amneal Pharmaceuticals, Inc.
Argenx SE
Astellas Pharma, Inc.
Avadel Pharmaceuticals PLC
Bausch Health Companies Inc.
Baxter International, Inc.
CSL Behring
CuraVac, Inc.
F. Hoffmann-La Roche, Ltd.
GlaxoSmithKline plc
Grifols SA
Immunovant, Inc.
Mitsubishi Tanabe Pharma Corp.
Novartis AG
RA Pharmaceuticals, Inc.
Takeda Pharmaceutical Co., Ltd.
UCB Pharma
Valeant Pharmaceuticals International, Inc.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/myasthenia-gravis-treatment-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: [email protected] Contact no: +91 780-304-0404